Special report critical decisions in drrhythmia management proceeding of a symposium Montreal, Quebec, Canada October 19, 1990
Use of disopyramide by arrhythmia specialists after Cardiac Arrhythmia Suppression Trial: Patient selection and initial outcome

https://doi.org/10.1016/0002-8703(91)90178-KGet rights and content

First page preview

First page preview
Click to open first page preview
View PDF

References (49)

  • S Kim et al.

    Combination of disopyramide and mexiletine for better tolerance and addictive effects for treatment of ventricular arrhythmias

    J Am Coll Cardiol

    (1989)
  • The Cardiac Arrhythmia Suppression Trial (CAST) Investigatiors

    Preliminary report. Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

    N Engl J Med

    (1989)
  • JT Bigger

    Implications of the cardiac arrhythmia suppresion trial for antiarrhythmic drug treatment

    Am J Cardiol

    (1990)
  • JN Ruskin

    The cardiac arrhythmia suppression trial (CAST)

    N Engl J Med

    (1989)
  • M Akhtar et al.

    CAST and beyond: implications of the cardiac arrhythmia suppression trial

    Circulation

    (1990)
  • CM Pratt et al.

    The cardiac arrhythmia suppression trial: background, interim results and implications

    Am J Cardiol

    (1990)
  • EN Prystowsky et al.

    Ventricular arrhythmias: risk stratification and approach to therapy after the cardiac arrhythmia suppression trial (CAST)

    PACE

    (1990)
  • Market Measures Inc.

    Arrhythmia Drug Market Study IX

    (May 1990)
  • RR Dean

    The pharmacology of Norpace

    Angiology

    (1975)
  • LA Siddoway

    Selecting appropriate first-line antiarrhythmic agents: comparative pharmacologic profiles

    PACE

    (1990)
  • R DiBianco

    Disopyramide for the treatment of cardiac arrhythmia

  • SL Teichman et al.

    Disopyramide-pyridostigmine: report of a beneficial drug interaction

    J Cardiovasc Pharmacol

    (1985)
  • E Patterson et al.

    Disopyramide plasma and myocardial tissue concentrations as they relate to anti-arrhythmic activity

    J Cardiovasc Pharmacol

    (1979)
  • PJ Meffin et al.

    The role of concentration-dependent plasma protein binding in disopyramide disposition

    J Pharmacokinet Biopharm

    (1979)

    • Cited by (0)

    View full text
    Copyright © 1990 Published by Mosby, Inc.